The Future of Pharmacogenomics: Integrating Epigenetics, Nutrigenomics, and Beyond
Author Information
Author(s): Shaman Jeffrey A.
Primary Institution: Coriell Life Sciences
Hypothesis
How can integrating epigenetics, nutrigenomics, and other biological factors enhance personalized medicine?
Conclusion
Integrating various biological factors with pharmacogenomics can significantly improve personalized medicine by optimizing drug efficacy and minimizing adverse effects.
Supporting Evidence
- Pharmacogenomics tailors drug treatments based on individual genetic profiles.
- Integrating epigenetics and nutrigenomics can enhance the understanding of drug responses.
- Multi-omics approaches can improve medication adherence and appropriateness.
Takeaway
This study looks at how understanding our genes and other biological factors can help doctors give us better, safer medicines that work just for us.
Methodology
The article reviews existing literature on pharmacogenomics and its integration with epigenetics, nutrigenomics, microbiomes, and other biological factors.
Potential Biases
Potential biases may arise from the complexity of integrating multi-omics data and the variability in individual responses.
Limitations
The integration of these approaches is not yet widely available in clinical practice due to cost barriers and technical challenges.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website